Literature DB >> 30773574

Influence of dialysis therapies on oral health: a pilot study.

Otília Pereira-Lopes, Liliana Simões-Silva, Ricardo Araujo, Joana Correia-Sousa, Ana C Braga, Isabel Soares-Silva, Benedita Sampaio-Maia.   

Abstract

OBJECTIVES: Chronic kidney disease (CKD) is a public health problem worldwide. Currently, the link between oral health status, dialysis modality, and dialysis vintage is still not clear. The aim of this study was to evaluate periodontal disease, dental caries, and Candida colonization among patients under hemodialysis (HD) therapy, peritoneal dialysis (PD) therapy, and PD with previous history of HD (HD/PD). METHOD AND MATERIALS: The clinical history, smoking, and oral hygiene habits were recorded. Decayed, missing, or filled teeth (DMFT) index, Visible Plaque Index (VPI), clinical attachment level (CAL), bleeding on probing, saliva flow rate, saliva pH, and oral yeast colonization were assessed.
RESULTS: HD/PD patients were generally submitted to longer periods of dialysis therapy than the other groups. The number of decayed and filled teeth did not differ between groups; HD patients presented a higher number of teeth, but poor periodontal status. Among the three groups, HD patients presented higher VPI, CAL, and oral Candida colonization, independently of the time under dialysis therapy. Candida albicans (HD and PD), Candida krusei (HD), and Candida carpophila (PD) were isolated in these patients.
CONCLUSION: HD presented a more adverse impact on oral health than PD, particularly periodontal disease and oral Candida colonization; however, this impact on oral health appears to be reduced or ameliorated when patients change from HD to PD therapy.

Entities:  

Keywords:  oral health; periodontal disease; renal insufficiency; renal replacement therapy; saliva; Candida

Mesh:

Year:  2019        PMID: 30773574     DOI: 10.3290/j.qi.a41920

Source DB:  PubMed          Journal:  Quintessence Int        ISSN: 0033-6572            Impact factor:   1.677


  1 in total

1.  Oral health-related quality of life in adult patients with end-stage kidney diseases undergoing renal replacement therapy - a systematic review.

Authors:  Gerhard Schmalz; Susann Patschan; Daniel Patschan; Dirk Ziebolz
Journal:  BMC Nephrol       Date:  2020-04-29       Impact factor: 2.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.